Korea tightens rules on experimental cell therapy

Published: 2006-09-18 06:58:00

Updated: 2006-09-18 06:58:00

The government is moving to make it more difficult to conduct clinical tests with stem cell therapy in emergency as problems arise from the fast-track processing of requests to conduct experimental cell therapy.

The Korea Food and Drug Administration (KFDA) said it will refrain from giving the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK